Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial.
Front Med. 2021 Jun;15(3):486-494. doi: 10.1007/s11684-020-0824-3. Epub 2021 Mar 9.
Front Med. 2021.
PMID: 33687643
Free PMC article.
Clinical Trial.